Showing results (371-380 of 432) with videos related to
Sort By:
Pageof 44
AJNR. American Journal of Neuroradiology|March 7, 2015
Enhanced axonal metabolism during early natalizumab treatment in relapsing-remitting multiple sclerosisO T Wiebenga, A M Klauser, M M Schoonheim, et al.Neurology|May 18, 2012
Brain atrophy accelerates cognitive decline in cerebral small vessel disease: the LADIS studyH Jokinen, J Lipsanen, R Schmidt, et al.Multiple Sclerosis (Houndmills, Basingstoke, England)|December 10, 2009
Primary progressive multiple sclerosis diagnostic criteria: a reappraisalX Montalban, J Sastre-Garriga, M Filippi, et al.AJNR. American Journal of Neuroradiology|March 12, 2016
White Matter Diffusion Changes during the First Year of Natalizumab Treatment in Relapsing-Remitting Multiple SclerosisO T Wiebenga, M M Schoonheim, H E Hulst, et al.Neurology|January 8, 2010
MRI criteria for MS in patients with clinically isolated syndromesX Montalban, M Tintoré, J Swanton, et al.Stroke|February 8, 2003
Visual rating of age-related white matter changes on magnetic resonance imaging: scale comparison, interrater agreement, and correlations with quantitative measurementsP Kapeller, R Barber, R J Vermeulen, et al.Neurology|January 5, 2002
The effect of IFNbeta-1b on the evolution of enhancing lesions in secondary progressive MSP A Brex, P D Molyneux, P Smiddy, et al.Journal of Neuroradiology = Journal De Neuroradiologie|November 15, 2017
Bullseye's representation of cerebral white matter hyperintensitiesC H Sudre, B Gomez Anson, I Davagnanam, et al.Multiple Sclerosis and Related Disorders|June 8, 2019
Long-term disease activity and disability progression in relapsing-remitting multiple sclerosis patients on natalizumabI Dekker, C E Leurs, M H J Hagens, et al.Journal of Neurology, Neurosurgery, and Psychiatry|May 16, 2000
One year follow up study of primary and transitional progressive multiple sclerosisV L Stevenson, D H Miller, S M Leary, et al.Pageof 44